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 ORIGINAL ARTICLE 
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Scandinavian Journal of Primary Health Care, 2010; 28: 82–88 Abstract 
 Objective. To describe an innovative team intervention to identify and resolve DRPs (drug-related problems) in Norwegian 
nursing homes.  Design. Descriptive intervention study . Setting. Three nursing homes in Bergen, Norway.  Subjects. A total 
of 142 long-term care patients (106 women, mean age 86.9 years).  Results. Systematic medication reviews performed by 
pharmacists in 142 patients revealed altogether 719 DRPs, of which 504 were acknowledged by the patients ’ physician and 
nurses, and 476 interventions were completed.  “ Unnecessary drug ” and  “ Monitoring required ” were the most frequently 
identifi ed DRPs. Drugs for treating the nervous system and the alimentary tract and metabolism were most commonly 
questioned.  Conclusions. The multidisciplinary team intervention was suitable to identify and resolve drug-related problems 
in nursing home settings. Systematic medication reviews and involvement of pharmacists in clinical teams should therefore 
be implemented on a regular basis to achieve and maintain high-quality drug therapy.  Key Words:  Drug-related problems ,  drug utilization review ,  nurses ,  nursing homes ,  physicians ,  patient care team ,  pharmacists  Nursing homes comprise about 40 000 beds and 
 constitute the largest institutional level in Norway. 
The institutions provide medical treatment and care 
services mainly to old patients with complex health 
problems and severe mental and functional impair-
ment. Drug therapy is an important treatment modality, 
and the majority of patients use multiple medications 
concurrently. However, age-related pharmacokinetic 
and pharmacodynamic changes, and co-morbidity 
pose great challenges to optimal drug therapy. Preva-
lence of DRPs (drug-related problems) is high in 
nursing home populations worldwide, e.g. extensive 
use of psychotropic medications and under-treatment 
of heart failure [1 – 7]. A DRP can be defi ned as  “ an 
event or circumstance involving drug therapy that 
actually or potentially interferes with desired health 
outcomes ” [8]. Studies from various countries and 
healthcare systems have shown that systematic medi-
cation reviews in nursing homes are effective in iden-
tifying DRPs [3,9,10], and  pharmacists ’ involvement  Correspondence: Kjell H. Halvorsen, Section for General Practice, Department 
31, N-5018 Bergen, Norway. E-mail: kjell.halvorsen@isf.uib.no 
 (Received 18 June 2009; accepted 22 February 2010) 
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DOI: 10.3109/02813431003765455has been shown to have a positive impact on the 
quality of medication use [11,12]. 
 Medical care for Norwegian nursing home 
patients is most commonly provided by part-time 
employed general practitioners. Consulting pharma-
cists are not usually active members of the institu-
tions ’ multidisciplinary teams. Collaboration with 
pharmacists may increase physicians ’ and nurses ’ 
knowledge and awareness of DRPs. 
 The aim of this study was to describe an innova-
tive team intervention to identify and resolve DRPs 
in Norwegian nursing homes. 
 Material and methods 
 Study population 
 At a nursing home conference in Bergen, Norway, 
directors and staff were informed about our study. 
Aiming at inclusion of 150 study patients, medium-sized of Public Health and Primary Health Care, University of Bergen, Kalfarveien 
orma Healthcare, Taylor & Francis AS)
 Drug-related problems in nursing homes 83 Nursing home patients are at great risk of 
experiencing drug-related problems. Appropri-
ate methods to handle these problems should 
be developed and evaluated. 
 Multidisciplinary case conferences between  •
pharmacists, physicians, and nurses are a 
suitable method to identify and solve 
 drug-related problems among nursing 
home patients. 
 Drug-related problems were most often  •
associated with unnecessary prescriptions 
and lack of therapeutic monitoring. 
 The most commonly questioned drugs  •
were those prescribed for treating the ner-
vous system and the alimentary tract and 
metabolism. nursing homes (60 – 75 beds) were invited to volun-
teer, and three randomly selected institutions were 
included. Eligible study subjects were long-term care 
patients   65 years, not terminally ill, who were 
using at least one regular medication. Nursing home 
staff was asked to include 50 patients per home at 
random, according to inclusion criteria during spring 
2006. 
 Baseline data collection 
 All study procedures (systematic review and case 
conferences) were piloted on 15 patients at a nursing 
home not participating in the study. 
 Baseline data collection and medication reviews 
were conducted by three experienced pharmacists 
employed at the Department of Pharmaceutical 
Advisory Services at Haukeland Hospital Pharmacy, 
Norway. Two pharmacists performed systematic 
reviews at one nursing home each, while one of them 
shared the last institution with a third pharmacist. 
Prior to, and during data collection, meetings were 
held with the pharmacists involved and the study 
supervisors (authors SR and AGG) to ensure consis-
tency of the review process and classifi cation of 
DRPs, and to discuss and resolve ambiguities. 
 Baseline data comprised patients ’ age and gender, 
diagnoses, relevant blood tests, and complete medi-
cation lists (brand name, formulation, strength, dos-
age, regular or p.r.n. (when required) medication and 
date of medication initiation). Patients ’ body weight 
and blood pressure were provided by nurses. All 
drugs were classifi ed according to the Anatomical 
Therapeutic Chemical system [13]. Based on 
 creatinine values, glomerular fi ltration rates were 
estimated [14].  Medication review 
 Each patient ’ s drug regimen was systematically reviewed 
by a pharmacist according to the criteria of a recently 
established Norwegian classifi cation tool [15], taking 
into account the patient ’ s individual clinical character-
istics. The assessment included available national treat-
ment recommendations [16,17] and a web-based tool 
for identifying drug – drug interactions, where severity is 
classifi ed according to a four-point scale [18]. The 
pharmacists identifi ed and classifi ed potential DRPs in 
individual patients (Table I) [15]. 
 Multidisciplinary case conferences 
 Nursing home physicians and nursing staff usually 
conduct weekly pre-round case conferences on the 
wards to discuss and resolve individual patients ’ health 
problems. For the purpose of this study, the pharma-
cists performing the medication reviews joined these 
meetings and presented identifi ed DRPs for groups of 
5 – 10 patients at a time to the patients ’ physician and 
primary nurse, inviting them to discuss and reconsider 
the problems. The identifi ed DRPs could be accepted, 
re-classifi ed (agreement that a problem is present, but 
classifi ed in another DRP category), or rejected, 
respectively. Furthermore, relevant interventions were 
planned to resolve the acknowledged DRPs, e.g. drug 
cessation, additional drug, dosage adjustment, or ther-
apeutic monitoring. In the case of disagreement 
between the health professionals concerning a DRP, 
the nursing home physician responsible for drug ther-
apy held the fi nal decision. 
 Outcome measures 
 Data were analysed with regard to DRPs (classifi cation 
shown in Table I) identifi ed by pharmacists and 
acknowledged at case conferences, medications 
involved, and interventions. Agreement between phar-
macists and clinical teams was considered as full agree-
ment (type of DRP and medication involved), partial 
agreement (type of DRP or medication involved), rejec-
tion, or additional DRP (identifi ed during case confer-
ence). Three weeks after the case conferences the 
pharmacists examined whether the planned interven-
tions had been completed, based on information in 
medical charts or provided by nursing home staff. 
 Ethics and approvals 
 The study was approved by the Regional Committee 
for Medical Research Ethics, the Norwegian Data 
Inspectorate, and the Norwegian Directorate for 
Health and Social Affairs. Information on the study 
was provided to each patient or adult offspring of 
mentally impaired patients. 
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 Table I. Drug-related problems (DRPs) in 142 nursing home patients as identifi ed by pharmacists and discussed at multidisciplinary case 
conferences. 
DRP category 15 
Medication review 














Drug choice problem 288 91 169 44 28 15 228
Need for additional drug 4 2 1 1 1 1 3
Unnecessary drug 235 71 144 38 20 12 194
Inappropriate drug choice 49 18 24 5 7 2 31
Dosing problem 127 46 60 13 21 7 80
Too high 85 25 47 9 13 2 58
Too low 22 10 7 2 5 4 13
Sub-optimal dosing scheme 17 9 6 2 2 1 9
Sub-optimal formulation 3 2  –  – 1  –  – 
Adverse reactions 9 8  – 1 1  – 1
Interactions 42 28 4  – 10  – 4
Inappropriate drug use 43 6 31 7 6  – 38
Administered by health personnel 43 6 31 6 6  – 37
Administered by patient  –  –  – 1  –  – 1
Other 210 64 107 39 38 6 153
Monitoring required 80 25 45 21 10 2 68
Unclear documentation 113 36 52 8 25  – 60
Not classifi ed/complex problem 17 3 11 10 3 4 25
Total 719 243 372 104 104 28 504 Statistical analysis 
 Data were analysed as a before-and-after study. Stu-
dent ’ s t-test and Wilcoxon rank-sum tests were per-
formed to compare groups. P-values   0.05 were 
considered statistically signifi cant. Software from 
SPSS version 14.0 was used. 
 Results 
 Nursing home staff at the three institutions selected at 
random 147 out of 216 patients, 142 of whom met the 
inclusion criteria. Women accounted for 74.6% and 
were generally older than men (87.7 vs. 84.6 years, p 
  0.05). Dementia (65% of all patients), hypertension 
(35%), and depression (34%) were the three most 
common diagnoses. On average each patient used 11.5 
drugs (8.1 regular medications and 3.4 drugs used 
p.r.n.). Lactulose, paracetamol, and acetylsalicylic acid 
were the most frequently used regular medications, 
while paracetamol, oxazepam, and paracetamol/
codeine combinations were the most common p.r.n. 
medications. The average number of drugs did not dif-
fer signifi cantly between the genders (p   0.46). 
 Drug-related problems 
 The pharmacists identifi ed 719 DRPs in 140 of the 
142 patients (mean per patient   5.1, SD   3.0). At 
the case conferences 476 of the identifi ed DRPs were accepted (full agreement was achieved on 372 (52%) 
DRPs, while 104 (14%) DRPs were accepted but 
re-classifi ed) and 243 (34%) DRPs were rejected. 
During the case conferences additionally 28 DRPs 
were identifi ed. Finally, 504 (mean per patient   3.5, 
SD   2.2) DRPs were acknowledged (Figure 1). 
 DRPs were most commonly classifi ed as  “ Unnec-
essary drug ” (33% of identifi ed, and 38% of acknow-
ledged DRPs), and  “ Monitoring required ” (11% of 
identifi ed, and 13% of acknowledged DRPs). Agree-
ment between pharmacists and clinical teams was 
most commonly achieved with regard to  “ Inappropri-
ate drug use  – administered by health personnel ” , 
while physicians and/or nurses often disagreed on 
 “ Adverse reactions ” and  “ Interactions ” (see Table I). 
 The drugs most commonly used were also those 
most frequently involved in DRPs: 219 (43%) of 
acknowledged DRPs were connected to 13 drugs, 
with paracetamol, lactulose, and zopiclone at the top 
(Table II). The most common rationale for, e.g., stat-
ing that there was no need for an analgesic, laxative, 
or anxiolytics/hypnotic in a particular patient was 
that these drugs were prescribed p.r.n. but had not 
been given within the preceding months. Drug dos-
ing was considered to be too high in the case of, e.g., 
paracetamol   4 grams/daily, zopiclone   5 mg/
daily, or lactulose   30 ml/daily. 
 Altogether 39 drug – drug interactions were identi-
fi ed by the intervention tool [18]. Two combinations 
were classifi ed as moderate severity and 37 combina-
tions as low severity. Three additional drug – drug 




























Figure 1. Drug-related problems (DRPs) in 142 nursing home patients as identifi ed by pharmacists and assessed by multidisciplinary 
clinical teams.interactions not detected by the tool were identifi ed 
by the pharmacists. 
 Interventions 
 The pharmacists proposed 694 interventions to 
resolve the 719 DRPs identifi ed. The physicians and 
nurses agreed to 504 interventions of which 472 
(94%) were implemented during the follow-up 
period. The most common interventions were  “ Drug 
cessation ” (e.g. p.r.n. analgesics, laxatives, and 
anxiolytics/hypnotics that were considered to be 
unnecessary),  “ Therapeutic monitoring ” (e.g. serum 
levels of cobolamine and serum levels of potassium 
in digitoxin users) and  “ Dose adjustment ” (e.g. dose 
reduction of paracetamol, zopiclone, and lactulose in  Table II. Drugs most commonly involved in drug-related problems in 
Acknowledged Drug-related 




Need for additional drug 1 1
Unnecessary drug 29 22
Inappropriate drug choice 2 1
Dosing problem
Too high 8 15
Too low 6  – 
Sub-optimal dosing scheme 1  – 
Sub-optimal formulation  –  – 
Adverse reactions  –  – 
Interactions 1  – 
Drug use problem
Administered by health personnel 3 1
Administered by patient  –  – 
Others
Monitoring required 1 1
Unclear documentation 4 5
Not classifi ed/complex problem 2 9
Total 58 55
 Notes:  a Paracetamol, paracetamol  codeine, tramadol,  b lactulose, sodium
folic acid, hydroxycobolamin,  e furosemide,  f acetylsalisylic acid,  g metoccases where prescribed doses were considered 
too high). Agreement levels between pharmacists 
and clinical teams varied with regard to type of inter-
vention,  “ Therapeutic monitoring ” and  “ Documen-
tation ” being the least likely to be initiated (Table 
III). Altogether 206 medications (63 regular) were 
discontinued, resulting in a mean reduction of 1.5 
drugs per patient (p   0.01). 
 Discussion 
 The team intervention was suitable to identify and 
resolve drug-related problems in nursing homes. On 
average, the pharmacists identifi ed 5.1 DRPs per 
study patient; 3.5 were acknowledged by physicians 
and nurses, of which 94% were followed up. 142 nursing home patients. 
Drug (group)
iolytics/





 –  – 1  –  – 3
25 9 2 1 11 99
1 1  – 1  – 6
9  – 4 4  – 40
 –  –  –  –  – 6
1  –  –  –  – 2
 –  –  –  –  –  – 
 –  –  – 1  – 1
 –  –  –  –  – 1
1 2 1 1  – 9
 – 1  –  –  – 1
1 9 6 1  – 19
3 2 1 2  – 17
3 1  –  –  – 15
44 25 15 11 11 219
 picosulphate, bisacodyl,  c zopiclone, oxazepam,  d vitamin b-complex/
lopramide. 
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3 weeks The three most commonly involved drugs
n (%) No. 1 drug(s) n No. 2 drug(s) n No. 3 drug(s) n




Dose adjustment 122 72 71 99 Paracetamol 12 Lactulose 10 Zopiclone 7
Therapeutic 
monitoring
104 73 61 84 Cobolamine 6 Digitoxin, 4 Furosemide, 
warfarin ∗ 
4
Documentation 87 51 41 80 Paracetamol 2 Acetylsalicylic 
acid
2 37 different drugs ∗ 1
Drug change 54 36 33 92 Lactulose 5 Paracetamol 3 Paroxetine 2
Other 72 62 58 94 7 different 
drugs  ∗ ,  ∗ ∗  
2 34 different 
drugs ∗ 
1
Additional drug 5 2 2 100 Paracetamol 1 Lactulose 1
Total 694 504 472 94
 Notes:  ∗ Number applies for each of the drugs,   ∗ ∗  donepezil, lactulose, lamotrigine, sodium picosulphate, laurylsulphate, budesonide/
formoterol and zopiclone.  Strengths and limitations 
 To our knowledge, this is the fi rst Norwegian study 
evaluating the impact of physician – pharmacist – nurse 
cooperation to optimize medication use in nursing 
homes. Detailed baseline data enabled comprehen-
sive medication reviews, and the criteria of the 
Norwegian DRP classifi cation system [15] ensured 
equal structure and conduct of the assessments. One 
advantage of the implicit review process is that it takes 
into account the clinical characteristics of each patient. 
The strengths of the process are the involvement of 
prescribers and nurses in the  decision-making on 
whether identifi ed issues were to be actioned or not. 
 The main limitation is that the study is small and 
that a control group was not included. Although a 
part-selection of patients cannot be ruled out, two 
out of three eligible patients were included, and the 
results of the study are probably relevant for other 
Norwegian nursing homes. The clinical information 
retrieved from patients ’ medical record is assumed to 
be based on correct diagnostic work-up, but we were 
not able to assess the validity and completeness of 
diagnoses. The intervention revealed a signifi cant 
reduction in number of medications. However, effects 
on clinical endpoints and drugs costs were not exam-
ined, as this was beyond the scope of this study. 
 Drug-related problems 
 Comparisons with other studies are hampered by 
methodological differences. The 3.5 acknowledged 
DRPs per patient in this study compare well to the 
3.5 DRPs per patient identifi ed by cooperating phy-
sicians and pharmacists in Dutch polypharmacy 
patients [2]. Medication review studies conducted in the UK [3] and Norway [5] revealed an average of 
2.5 DRPs per patient. These differences may be 
explained by different study populations, fewer clin-
ical data available, or lack of contribution of nursing 
home physicians and nurses. Our fi ndings that drugs 
affecting the nervous system and alimentary tract 
and metabolism were often involved in DRPs are in 
line with previous studies [2,5]. 
 Multidisciplinary case conferences 
 The multidisciplinary meetings in this study repre-
sent an extension of established case conferences 
between physicians and nurses, turning to account 
for the complementary knowledge of pharmacists. 
Presenting their medication review fi ndings and 
 recommendations at face-to-face meetings, the 
 pharmacists were able to facilitate discussions and 
decision-making with regard to DRPs. On the other 
hand, the physicians and nurses provided additional 
clinical information based on their profound patient 
knowledge that was essential to make fi nal decisions 
on DRPs and appropriate interventions. Controlled 
studies by Schmidt et al. [19] and Crotty et al. [20] 
indicate that direct communication and teamwork by 
physicians, pharmacists, and nurses are effective for 
improving psychotropic prescribing and nursing 
home staff  ’ s drug therapy knowledge [19], and for 
improving overall prescribing quality [20]. 
 The effectiveness of medication reviews by phar-
macists can be evaluated by means of acceptance rates 
by physicians of the pharmacists ’ recommendations. 
Our study revealed 66% acceptance, and 94% imple-
mentation of accepted DRPs. Previous studies report 
acceptance rates between 39% and 92% [3,4,21]. This 
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when addressing DRPs. Direct communication 
between healthcare providers in general reveals higher 
acceptance rates [3,21] than indirect contact, e.g. 
written reports [4]. The physician – pharmacist meet-
ings conducted by Finkers et al. [2] as well as in the 
present study provided an opportunity to discuss, 
acknowledge, adjust, and reject DRPs raised by the 
pharmacists, and to add new problems to the list. This 
proactive approach may also have contributed to the 
high rate of problem-solving achieved in this study 
(see Table III), as interventions were planned and 
partly executed during the case conferences. 
 We found that agreement between pharmacists 
and clinical teams varied with regard to different 
DRP categories (see Table I). Only 10% of the 
identifi ed drug – drug interactions were accepted by 
the clinical teams, while proposed DRPs regarding 
 “ Unnecessary drug ” and  “ Unclear documentation ” 
were highly accepted. This is possibly explained by 
the fact that most interactions were considered of 
minor clinical importance. Another explanation is 
that risk – benefi t analyses have already been 
performed by physicians when prescribing the actual 
drugs and combinations. A third explanation may be 
that physicians consider inquiries concerning their 
drug therapy decisions to be a threat to their 
professional position. 
 Although 94% of all planned interventions were 
conducted, somewhat lower completion rates were 
found for  “ documentation ” and  “ monitoring ” . 
Three weeks may have been too short for the staff 
to initiate more time-consuming interventions. 
Follow-up periods in medication review studies 
vary from three weeks to 12 months; however, 
numbers of subjects lost to follow-up due to terminal 
illness and death may increase with the time 
window [2,3,19,21]. 
 Conclusions 
 In our experience, the multidisciplinary meetings in 
general contributed to increased knowledge and 
 critical refl ections on drug treatment and can poten-
tially improve the long-term communication between 
team members, and hence the quality of the patients ’ 
drug treatment. Policy-makers should consider imple-
menting systematic medication reviews on a regular 
basis to achieve and maintain high-quality drug treat-
ment in nursing home patients. Future research should 
include clinical end-points to substantiate benefi cial 
patient-related outcomes, e.g. reductions in side-
effects, and possible cost-savings. Furthermore, 
prescribing quality in larger geriatric populations 
should be surveyed, based on suitable indicators, e.g. 
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